| Q90569831 | A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches |
| Q57021562 | A Critical Exploration of Migraine as a Health Disparity: the Imperative of an Equity-Oriented, Intersectional Approach |
| Q36771091 | A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine |
| Q47749005 | A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine |
| Q90637725 | Acupuncture methods for acute migraine attack: a Bayesian network meta-analysis protocol |
| Q34471863 | Acute Migraine Treatment in Adults |
| Q93197651 | Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial |
| Q90075643 | Acute treatment patterns in patients with migraine newly initiating a triptan |
| Q90723631 | An Evidence-Based Review of Fremanezumab for the Treatment of Migraine |
| Q91827563 | Assessment Of Spanlastic Vesicles Of Zolmitriptan For Treating Migraine In Rats |
| Q54920214 | Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine. |
| Q38700966 | Chronic Daily Headache: Mechanisms and Principles of Management |
| Q38795561 | Clinical update on benefit versus risks of oral paracetamol alone or with codeine: still a good option? |
| Q92574534 | Comparing the Therapeutic Effects of Dexamethasone-Metoclopramide with Ketorolac in Relieving Headache in Patients with Acute Migraine Attacks Presenting to the Emergency Department |
| Q90726206 | Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response |
| Q55078810 | Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits. |
| Q38808208 | Considerations for management of migraine symptoms in the primary care setting |
| Q38749921 | Cutaneous Adverse Effects of Neurologic Medications |
| Q64086230 | DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment |
| Q38872695 | Delayed absorption of many (paracetamol, aspirin, other NSAIDs and zolmitriptan) but not all (sumatriptan, rizatriptan) drugs during migraine attacks and most likely normal gastric emptying outside attacks. A review |
| Q92261200 | Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients |
| Q36925875 | Diagnosis and treatment for chronic migraine |
| Q33633047 | Diclofenac potassium for oral solution (CAMBIA®) in the acute management of a migraine attack: clinical evidence and practical experience |
| Q36387731 | Dietary and Lifestyle Changes in the Treatment of a 23-Year-Old Female Patient With Migraine |
| Q58798614 | Dynamic sodium imaging at ultra-high field reveals progression in a preclinical migraine model |
| Q58769031 | Effects of Add-On Ultramicronized N-Palmitol Ethanol Amide in Patients Suffering of Migraine With Aura: A Pilot Study |
| Q58778662 | Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study |
| Q44093966 | Efficacy and safety of DFN-15, an oral liquid formulation of celecoxib, in adults with migraine: a multicenter, randomized, placebo-controlled, double-blind, crossover study |
| Q39015227 | Efficacy of Noninvasive Brain Stimulation on Pain Control in Migraine Patients: A Systematic Review and Meta-Analysis. |
| Q28074159 | Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response |
| Q90439918 | Emergency Department and Inpatient Management of Headache in Adults |
| Q57021554 | Episodic Migraine With and Without Aura: Key Differences and Implications for Pathophysiology, Management, and Assessing Risks |
| Q48249123 | Ergotamine Use and Overuse in Taiwan: A Retrospective Cohort Study. |
| Q88334993 | Evidence-based review and appraisal of the use of droperidol in the emergency department |
| Q47355845 | External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: Open-Label Trial on Safety and Efficacy |
| Q38790950 | Gender Differences in the Use of Complementary and Alternative Medicine and Their Association With Moderate Mental Distress in U.S. Adults With Migraines/Severe Headaches |
| Q26801534 | Headache and Tremor: Co-occurrences and Possible Associations |
| Q30240827 | How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management? |
| Q50795275 | How to Apply the AHS Evidence Assessment of the Acute Treatment of Migraine in Adults to your Patient with Migraine. |
| Q36967962 | Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients |
| Q38725439 | Indomethacin Responsive Headaches: Exhaustive Systematic Review with Pooled Analysis and Critical Appraisal of 81 Published Clinical Studies |
| Q41161071 | Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study. |
| Q37666402 | Ketorolac versus Magnesium Sulfate in Migraine Headache Pain Management; a Preliminary Study |
| Q92977138 | Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials |
| Q58782738 | Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation |
| Q93353115 | Lifestyle modifications as therapy for medication refractory post-traumatic headache (PTHA) in the military population of Okinawa |
| Q58087510 | Management of Episodic Migraine in Children and Adolescents: a Practical Approach |
| Q38784408 | Managing Migraine During Pregnancy and Lactation |
| Q64965457 | Managing tooth pain in general practice. |
| Q50016837 | Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study |
| Q36535390 | Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat |
| Q88012546 | Migraine |
| Q49873285 | Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action |
| Q47762490 | Migraine prevalence in inflammatory bowel disease patients: A tertiary-care centre cross-sectional study |
| Q39340622 | Migraines in Women: Current Evidence for Management of Episodic and Chronic Migraines. |
| Q92238062 | Network Meta-Analysis of Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine |
| Q30831647 | Network meta-analysis of migraine disorder treatment by NSAIDs and triptans |
| Q56363416 | Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study |
| Q57988151 | OCT1 mediates hepatic uptake of sumatriptan and loss-of-functionOCT1polymorphisms affect sumatriptan pharmacokinetics |
| Q104500100 | Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial |
| Q30398062 | Persistent Postural-Perceptual Dizziness: A Matter of Higher, Central Dysfunction? |
| Q40160353 | Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion |
| Q88716799 | Pharmacokinetics and Skin Tolerability of Intracutaneous Zolmitriptan Delivery in Swine Using Adhesive Dermally Applied Microarray |
| Q42359900 | Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy Volunteers |
| Q38665422 | Phase 1, Randomized, Double-blind, Placebo-controlled, Single-dose and Multiple-dose Studies of Erenumab in Healthy Subjects and Patients With Migraine. |
| Q92319274 | Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine |
| Q33698292 | Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy |
| Q38476100 | Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse |
| Q90285628 | Progress in Neuroengineering for brain repair: New challenges and open issues |
| Q33565338 | Randomized Trial of Adding Parenteral Acetaminophen to Prochlorperazine and Diphenhydramine to Treat Headache in the Emergency Department |
| Q46377572 | Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine |
| Q47883597 | Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray |
| Q26743537 | Recent advances in migraine therapy |
| Q92085589 | Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications |
| Q47309054 | Side effects associated with current and prospective antimigraine pharmacotherapies. |
| Q55031304 | Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache. |
| Q38967012 | Sumatriptan Nasal Powder: A Review in Acute Treatment of Migraine |
| Q38804198 | Sumatriptan iontophoretic transdermal system for acute treatment of episodic migraine |
| Q38656208 | Sumatriptan/Naproxen Sodium: A Review in Migraine |
| Q36590544 | Survey of Opioid and Barbiturate Prescriptions in Patients Attending a Tertiary Care Headache Center |
| Q91625473 | The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings |
| Q58805324 | The adult patient with headache |
| Q91589079 | The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis |
| Q38853704 | The efficacy and safety of sumatriptan intranasal powder in adults with acute migraine |
| Q92861073 | The first comparative double-blind trial on efficacy and safety of ergotamine based five-component combination and sumatriptan in migraine without aura |
| Q90497079 | The metabolic face of migraine - from pathophysiology to treatment |
| Q47788175 | The pathophysiology of migraine: implications for clinical management |
| Q38563244 | The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine |
| Q31005037 | Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly® Device for Migraine Prevention: A Review of the Available Data |
| Q53510678 | Treatment of headache following triptan failure after successful triptan therapy. |
| Q40896902 | Triptan use among hospital workers affected by migraine. |
| Q38994955 | Triptans and migraine: advances in use, administration, formulation, and development |
| Q39173843 | Triptans for Acute Migraine Headache: Current Experience With Triptan Use and Prescription Habits in a Tertiary Care Headache Outpatient Clinic: An Observational Study |
| Q89776215 | Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II |
| Q92608909 | Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study |
| Q40743726 | Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache |
| Q55235463 | Which is more effective for the treatment of Acute Migraine Attack: Dexketoprofen, Ibuprofen or Metoclopramide? |
| Q36130277 | Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial |
| Q95262055 | [Repurposing chlorpromazine to treat COVID-19: the reCoVery study] |
| Q94587790 | [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study] |